Public Health addresses FDA and Moderna approval

The Plumas County Public Health Agency announced that the U.S. Food and Drug Administration approved a second COVID-19 vaccine —Moderna, but going forward Moderna will be marketed as Spikevax for the prevention of COVID-19 in individuals 18 years of age and older. The FDA had already approved the Pfizer vaccine.

Spikevax has the same formulation as the emergency use authorized Moderna COVID-19 Vaccine and is administered as a primary series of two doses, one month apart.

Spikevax can be used interchangeably with the EUA Moderna COVID-19 Vaccine to provide the COVID-19 vaccination series. Moderna COVID- 19 Vaccine remains available under EUA as a two-dose primary series for individuals 18 years of age and older, as a third primary series dose for individuals 18 years of age and older who have been determined to have certain kinds of immunocompromise, and as a single booster dose for individuals 18 years of age and older at least five months after completing a primary series of the vaccine.

It is also authorized for use as a heterologous (or “mix and match”) single booster dose for individuals 18 years of age and older following completion of primary vaccination with a different available COVID-19 vaccine.

COVID-19 vaccines are readily available in Plumas County at all pharmacies, Eastern Plumas Health Care, Plumas District Hospital, and Plumas County Public Health Clinic.

For more information go to county website https://www.plumascounty.us/2839/COVID-19-Home